中国医药
中國醫藥
중국의약
CHINA MEDICINE
2014年
9期
1350-1354
,共5页
张婷%郎宇%蔡兵%赵磊%许亚超%张瑛
張婷%郎宇%蔡兵%趙磊%許亞超%張瑛
장정%랑우%채병%조뢰%허아초%장영
人工流产%丙泊酚%靶控输注%瑞芬太尼%地佐辛
人工流產%丙泊酚%靶控輸註%瑞芬太尼%地佐辛
인공유산%병박분%파공수주%서분태니%지좌신
Artificial abortion%Propofol%Target-controlled infusion%Remifentanil%Dezocine
目的:探讨靶控输注丙泊酚复合瑞芬太尼、地佐辛用于无痛人工流产术的有效性和安全性。方法选择60例美国麻醉医师协会( ASA)分级Ⅰ~Ⅱ级行无痛人工流产术的患者,将患者完全随机分为2组,靶控输注丙泊酚组( TCI组)和手控输注丙泊酚组( MCI组),每组30例。 TCI组设定丙泊酚初始血浆靶浓度为6 mg/L,术中根据手术进程滴定目标靶浓度;MCI组以丙泊酚2 mg/kg诱导,术中发生体动反应时追加丙泊酚20~30 mg。2组均在术前5 min静脉滴注地佐辛5 mg,入睡后即刻小壶滴注瑞芬太尼1μg/kg。观察并记录2组丙泊酚的总用量、麻醉效能、术中呼吸循环的变化及术后不良反应等指标。结果 TCI组丙泊酚的总用量为(2.55±0.34)mg/kg,明显大于MCI组的(2.10±0.20)mg/kg(P<0.01);TCI组麻醉效果优的比例高于MCI组[83.3%(25/30)比53.3%(16/30),P<0.05]、术中体动反应的发生率低于MCI组[16.7%(5/30)比46.7%(14/30),P <0.05];除诱导时间 TCI 组[(1.27±0.15) min]长于 MCI 组[(1.09±0.15)min]外,2组患者的手术时间、意识恢复时间、清醒时间差异均无统计学意义;麻醉诱导后,2组患者的平均动脉压、心率均下降(均P<0.01),但2组间差异无统计学意义(P>0.05),术毕时平均动脉压均回升至术前水平;2组患者均无明显的术后宫缩痛。结论丙泊酚靶控输注复合瑞芬太尼、地佐辛用于无痛人工流产术麻醉效果安全舒适,麻醉深度易于控制,但术中须注意对患者呼吸功能的支持。
目的:探討靶控輸註丙泊酚複閤瑞芬太尼、地佐辛用于無痛人工流產術的有效性和安全性。方法選擇60例美國痳醉醫師協會( ASA)分級Ⅰ~Ⅱ級行無痛人工流產術的患者,將患者完全隨機分為2組,靶控輸註丙泊酚組( TCI組)和手控輸註丙泊酚組( MCI組),每組30例。 TCI組設定丙泊酚初始血漿靶濃度為6 mg/L,術中根據手術進程滴定目標靶濃度;MCI組以丙泊酚2 mg/kg誘導,術中髮生體動反應時追加丙泊酚20~30 mg。2組均在術前5 min靜脈滴註地佐辛5 mg,入睡後即刻小壺滴註瑞芬太尼1μg/kg。觀察併記錄2組丙泊酚的總用量、痳醉效能、術中呼吸循環的變化及術後不良反應等指標。結果 TCI組丙泊酚的總用量為(2.55±0.34)mg/kg,明顯大于MCI組的(2.10±0.20)mg/kg(P<0.01);TCI組痳醉效果優的比例高于MCI組[83.3%(25/30)比53.3%(16/30),P<0.05]、術中體動反應的髮生率低于MCI組[16.7%(5/30)比46.7%(14/30),P <0.05];除誘導時間 TCI 組[(1.27±0.15) min]長于 MCI 組[(1.09±0.15)min]外,2組患者的手術時間、意識恢複時間、清醒時間差異均無統計學意義;痳醉誘導後,2組患者的平均動脈壓、心率均下降(均P<0.01),但2組間差異無統計學意義(P>0.05),術畢時平均動脈壓均迴升至術前水平;2組患者均無明顯的術後宮縮痛。結論丙泊酚靶控輸註複閤瑞芬太尼、地佐辛用于無痛人工流產術痳醉效果安全舒適,痳醉深度易于控製,但術中鬚註意對患者呼吸功能的支持。
목적:탐토파공수주병박분복합서분태니、지좌신용우무통인공유산술적유효성화안전성。방법선택60례미국마취의사협회( ASA)분급Ⅰ~Ⅱ급행무통인공유산술적환자,장환자완전수궤분위2조,파공수주병박분조( TCI조)화수공수주병박분조( MCI조),매조30례。 TCI조설정병박분초시혈장파농도위6 mg/L,술중근거수술진정적정목표파농도;MCI조이병박분2 mg/kg유도,술중발생체동반응시추가병박분20~30 mg。2조균재술전5 min정맥적주지좌신5 mg,입수후즉각소호적주서분태니1μg/kg。관찰병기록2조병박분적총용량、마취효능、술중호흡순배적변화급술후불량반응등지표。결과 TCI조병박분적총용량위(2.55±0.34)mg/kg,명현대우MCI조적(2.10±0.20)mg/kg(P<0.01);TCI조마취효과우적비례고우MCI조[83.3%(25/30)비53.3%(16/30),P<0.05]、술중체동반응적발생솔저우MCI조[16.7%(5/30)비46.7%(14/30),P <0.05];제유도시간 TCI 조[(1.27±0.15) min]장우 MCI 조[(1.09±0.15)min]외,2조환자적수술시간、의식회복시간、청성시간차이균무통계학의의;마취유도후,2조환자적평균동맥압、심솔균하강(균P<0.01),단2조간차이무통계학의의(P>0.05),술필시평균동맥압균회승지술전수평;2조환자균무명현적술후궁축통。결론병박분파공수주복합서분태니、지좌신용우무통인공유산술마취효과안전서괄,마취심도역우공제,단술중수주의대환자호흡공능적지지。
Objective To evaluate the efficacy and safety of propofol by target-controlled infusion (TCI) combined with remifentanil and dezocine for artificial abortion .Methods According to the different anesthesia , sixty patients were randomly divided into two groups in chronological order ( n=30 each ):group TCI and group manual-controlled infusion (group MCI).The initial target plasma concentration of group TCI was 6 mg/L, titra-ting the goal target concentration during the surgical process .The induction dose of propofol was 2 mg/kg in group MCI, supplying propofol by 20-30 mg.5 mg dezocine was infused 5 minutes before anesthesia and 1 μg/kg remifentanil was infused immediately after sleeping for each group .The anesthetic effect , change of respiration and circulation , total dose of propofol and side-effect of operation were observed and recorded .Results Total dose of propofol used in group TCI was (2.55 ±0.34) mg/kg,which was significantly more than that of group MCI [(2.10 ±0.20)mg/kg] (P<0.01).Compared with group MCI, the ratio of excellent anesthesia in group TCI was higher [83.3%(25/30) vs 53.3%(16/30), P<0.05], and the incidence of body movement was less in group TCI [16.7%(5/30) vs 46.7%(14/30), P<0.05].The induced time in group TCI was (1.27 ± 0.15)min, which was longer than that of group MCI [(1.09 ±0.15) min, P<0.01], but there was no signifi-cant difference in the recovery time between the two groups .The mean arterial pressure ( MAP) and heart rate (HR) were lower after induction (P<0.01), but the MAP returned to normal at the end of surgery in both groups.The changes of MAP and HR in group TCI and group MCI were not significantly different (P>0.05).No severe postoperative pain from uterine contraction occurred in all the patients .Conclusions Target-controlled in-fusion of propofol combined with remifentanil and dezocine for artificial abortion is safe and effective with good con -trollability, but respiratory support should be provided during the surgical procedure .